Susquehanna International Group
SPRB

Susquehanna International Group’s Spruce Biosciences SPRB Stock Holding History

Susquehanna International Group’s Portfolio SPRB Stock Details SPRB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-193
Closed -$6.82K – 13482
2024
Q3 		$6.82K Buy
193
+25
+15% +$916 ﹤0.01% 11742
2024
Q2 		$6.55K Buy
+168
New +$9.01K ﹤0.01% 11808

Other funds holding SPRB

CG
Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.29% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Susquehanna International Group's SPRB Position: Q1 2025 in Review

Susquehanna International Group sold out of Spruce Biosciences (SPRB) in Q1 2025, closing a stake of 786 shares — an estimated $24.8K sold.

Susquehanna International Group first reported a position in SPRB in Q4 2021 and held it in 3 quarters. The position peaked at $122K in Q4 2021. 31 funds tracked by Wall St. Rank hold SPRB as of Q1 2025.

  • Susquehanna International Group reported no remaining Spruce Biosciences position as of Q1 2025 after selling out during the quarter.
  • Susquehanna International Group sold 786 Spruce Biosciences shares in Q1 2025, an estimated $24.8K.
  • Susquehanna International Group first reported a position in Spruce Biosciences in Q4 2021 and held it in 3 quarters.
  • Susquehanna International Group's Spruce Biosciences position peaked at $122K in Q4 2021.
  • 31 funds tracked by Wall St. Rank held Spruce Biosciences as of Q1 2025.

Based on Susquehanna International Group's 13F filing for Q1 2025, filed 14 May 2025.